Stay updated on Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.

Latest updates to the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, representing an updated version of the study page.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page’s revision tag was updated from v3.6.3 to v3.6.4, signaling a new version of the page or its backend patch. This change reflects an internal update rather than a substantive modification to the displayed information.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, indicating a small maintenance update to the page metadata.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision: v3.6.2 was added, replacing the previous v3.6.0. This reflects a minor administrative update to the page’s revision history.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page now indicates recruitment has ended ('No longer looking for participants'), adds user-help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a new 'Intervention/Treatment' section, replaces the old 'Intervention / Treatment' heading, and updates the Revision tag from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check69 days agoChange DetectedThe page’s revision tag changed from v3.5.4 to v3.5.5, signaling a minor update to the ClinicalTrials.gov study page without changing the study content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab, Cabiralizumab, SBRT in Pancreatic Cancer Clinical Trial page.